Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas
- PMID: 21896959
- PMCID: PMC3248213
- DOI: 10.18632/oncotarget.319
Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas
Abstract
Glioblastoma multiforme (GBM) is the most common and lethal of human primary central nervous system (CNS) tumors, with a median survival of 14-16 months despite optimal surgery, radiation and chemotherapy. A reason for this dismal prognosis is insufficient understanding of the ontogeny of GBMs, which are highly heterogeneous at a pathological level. This pathological diversity, between and within GBMs as well as varying grades of gliomas, has not been fully explained solely on the grounds of oncogenic stimulus. Interaction with the tumor microenvironment is likely a source of this pathological heterogeneity, as well as the inherent characteristics of the tumor cell of origin. Currently, controversy exists on whether the initial transformed cell is a differentiated astrocyte, progenitor or neural stem cell. Putative cancer stem cells (CSCs), which have features of normal stem cell plus the ability to recapitulate the tumor phenotype in vivo in small numbers, have been identified from a variety of solid human cancers, including GBMs. Evidence suggesting that regions harboring normal stem cells in the adult CNS, such as the subventricular zone and the dentate gyrus, are more prone to viral and chemical oncogenesis, is supportive of the hypothesis that brain tumors arise from stem cells. However, it is still to be determined whether the appearance of brain tumor stem cells (BTSC) is the cause or consequence of tumor initiation and progression. This review discusses emerging evidence highlighting the relevance of the state of differentiation and regional heterogeneity in the ontogeny of GBM. This is an area of high interest in cancer in general, with potential significant therapeutic and prognostic implications.
Figures

Similar articles
-
Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.Cells. 2021 Mar 11;10(3):621. doi: 10.3390/cells10030621. Cells. 2021. PMID: 33799798 Free PMC article. Review.
-
Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).Int J Mol Med. 2018 Aug;42(2):691-702. doi: 10.3892/ijmm.2018.3668. Epub 2018 May 10. Int J Mol Med. 2018. PMID: 29749540 Free PMC article. Review.
-
Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29. Protein Cell. 2010. PMID: 21203936 Free PMC article. Review.
-
Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.Mol Cancer. 2025 Mar 4;24(1):64. doi: 10.1186/s12943-025-02273-2. Mol Cancer. 2025. PMID: 40033380 Free PMC article.
-
Targeting role of glioma stem cells for glioblastoma multiforme.Curr Med Chem. 2013;20(15):1974-84. doi: 10.2174/0929867311320150004. Curr Med Chem. 2013. PMID: 23317162 Review.
Cited by
-
Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.PLoS One. 2013;8(2):e56691. doi: 10.1371/journal.pone.0056691. Epub 2013 Feb 12. PLoS One. 2013. PMID: 23424671 Free PMC article.
-
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells.Oncotarget. 2013 Aug;4(8):1280-92. doi: 10.18632/oncotarget.1176. Oncotarget. 2013. PMID: 23907569 Free PMC article.
-
Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.J Neurooncol. 2014 Jan;116(2):207-12. doi: 10.1007/s11060-013-1308-y. Epub 2013 Nov 17. J Neurooncol. 2014. PMID: 24242756 Review.
-
Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila.Biomed Res Int. 2017;2017:2690187. doi: 10.1155/2017/2690187. Epub 2017 Dec 27. Biomed Res Int. 2017. PMID: 29445734 Free PMC article.
-
ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.Transl Neurosci. 2013 Dec;4(4):484-503. doi: 10.2478/s13380-013-0148-8. Transl Neurosci. 2013. PMID: 25530875 Free PMC article.
References
-
- Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia. 1995;15:211–221. - PubMed
-
- Kleihues PSL. World health organization classification of tumors. cancer. 2000;88:2887. - PubMed
-
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996. - PubMed
-
- Rakic P. DNA synthesis and cell division in the adult primate brain. Ann N Y Acad Sci. 1985;457:193–211. - PubMed
-
- Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124:319–335. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical